- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00975949
Neurodevelopmental Outcomes and Fluconazole Prophylaxis (NDFP)
Neurodevelopmental Outcomes and Quality of Life and Fluconazole Prophylaxis
Study Overview
Detailed Description
Invasive fungal infections in preterm infants is associated with significant morbidity and mortality. Mortality in infected infants < 1000 grams is between 26-66% and neurodevelopmental impairment occurs in 57%.1-13 Between 1998-2000 we conducted a randomized placebo controlled trial of fluconazole prophylaxis in 100 infants <1000 grams at birth(IRB-HSR #9389). Invasive fungal infections occurred in none of the fluconazole-treated patients compared to 20% of the placebo group. Following this study the efficacy has been confirmed in a multicenter randomized controlled trial and 7 retrospective studies. One major issue that has remained is whether the fluconazole-treated infants have better neurodevelopmental outcomes as well as if it is safe without an increase in neurodevelopmental impairment.
Neurodevelopmental outcomes can be assessed by testing and examinations or by parental and child questionnaires. In addition, quality of life is an important context of outcomes. Recent conceptualizations of quality of life recognize the multidimensional nature of quality of life, including psychological and social functioning, consistent with the World Health Organization's definition of health as "not only the absence of disease and infirmity, but the presence of physical, mental, and social well-being." The World Health Organization subsequently emphasized the growing consensus that quality of life is a subjective experience, defined as "individuals' perceptions of their position in life in the context of the culture and value systems in which they live, and in relation to their goals, expectations, standards, and concerns."
To address these issues, we aim to study and compare the neurodevelopmental outcome and quality of life between our fluconazole-treated and placebo-treated patients in our initial study
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Neonatal Intensive Care Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Parents or guardians and their infants who survived and were enrolled in our initial study of fluconazole prophylaxis for prevention of fungal colonization and infection in preterm infants < 1000 grams
Exclusion Criteria:
- Persons not meeting the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Fluconazole Group
These subjects received fluconazole in our NICU fluconazole prophylaxis study during 1998-2000
|
Parents of subjects were interviewed and two surveys were obtained, the Child Health Questionnaire and the Vineland-II.
|
Placebo Group
These subjects received a placebo during our NICU fluconazole prophylaxis study during 1998-2000
|
Parents of subjects were interviewed and two surveys were obtained, the Child Health Questionnaire and the Vineland-II.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Neurodevelopmental impairment and poor quality of life
Time Frame: 7 to 10 years after participation in the initial study of fluconazole prophylaxis for prevention of fungal colonization and infection in preterm infants <1000 grams
|
7 to 10 years after participation in the initial study of fluconazole prophylaxis for prevention of fungal colonization and infection in preterm infants <1000 grams
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David Kaufman, MD, University of Virginia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 13697
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodevelopmental Outcomes
-
Women and Infants Hospital of Rhode IslandCompletedPremature Infant | Language Development | Neurodevelopmental OutcomesUnited States
-
Tarah T ColaizyEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedNeurodevelopmental Outcomes of VLBW InfantsUnited States
-
IWK Health CentreDalhousie UniversityRecruiting
-
Zimmer BiometActive, not recruitingClinical Outcomes | Survivorship | Safety | Functional Outcomes | Radiological OutcomesUnited States
-
Third Military Medical UniversityCompletedPerioperative Outcomes | Oncological OutcomesChina
-
ModernaTX, Inc.CompletedPregnancy | Maternal Outcomes | Infant OutcomesUnited States
-
University of LiegeCompletedIntraoperative Outcomes | Postoperative Outcomes
-
Teachers College, Columbia UniversityColumbia UniversityNot yet recruitingAdverse Childhood Experiences | Mental Health Outcomes | Perceived School Safety | Educational Outcomes
-
Peking Union Medical College HospitalUnknown
-
Stony Brook UniversityRecruiting
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Lawson Health Research InstituteCompletedEvaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation ParticipationMyocardial Infarction | Unstable Angina | Coronary Angioplasty | Coronary Artery Bypass SurgeryCanada
-
University GhentCompletedStroke | Upper Extremity Paresis | Survey
-
Assistance Publique - Hôpitaux de ParisUniversité de Cergy PontoiseCompleted
-
Weill Medical College of Cornell UniversityBoston Children's Hospital; Brigham and Women's Hospital; The Commonwealth FundCompletedPediatric ALLUnited States